SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001285
Filing Date
2019-09-17
Accepted
2019-09-17 17:00:44
Documents
12
Period of Report
2019-09-13
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529558_8k.htm   iXBRL 8-K 24180
  Complete submission text file 0001410578-19-001285.txt   194720

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20190913.xsd EX-101.SCH 3175
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20190913_lab.xml EX-101.LAB 33476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20190913_pre.xml EX-101.PRE 21951
7 EXTRACTED XBRL INSTANCE DOCUMENT tv529558_8k_htm.xml XML 3610
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 191097628
SIC: 2834 Pharmaceutical Preparations